Ondari Edna M, Heath Jennifer N, Klemm Elizabeth J, Langridge Gemma, Barquist Lars, Goulding David A, Clare Simon, Dougan Gordon, Kingsley Robert A, MacLennan Calman A
Swiss Tropical Public Health Institute, Basel, Switzerland.
Novartis Vaccines Institute for Global Health, Siena, Italy.
Infect Immun. 2017 Aug 18;85(9). doi: 10.1128/IAI.00419-17. Print 2017 Sep.
The ST313 pathovar of serovar Typhimurium contributes to a high burden of invasive disease among African infants and HIV-infected adults. It is characterized by genome degradation (loss of coding capacity) and has increased resistance to antibody-dependent complement-mediated killing compared with enterocolitis-causing strains of Typhimurium. Vaccination is an attractive disease-prevention strategy, and leading candidates focus on the induction of bactericidal antibodies. Antibody-resistant strains arising through further gene deletion could compromise such a strategy. Exposing a saturating transposon insertion mutant library of Typhimurium to immune serum identified a repertoire of Typhimurium genes that, when interrupted, result in increased resistance to serum killing. These genes included several involved in bacterial envelope biogenesis, protein translocation, and metabolism. We generated defined mutant derivatives using Typhimurium SL1344 as the host. Based on their initial levels of enhanced resistance to killing, and mutants were selected for further characterization. The Typhimurium mutant lost the characteristic rod-shaped appearance, exhibited increased sensitivity to osmotic and detergent stress, lacked very long lipopolysaccharide, was unable to invade enterocytes, and demonstrated decreased ability to infect mice. In contrast, the Typhimurium mutants had similar sensitivity to osmotic and detergent stress and lipopolysaccharide profile and an increased ability to infect enterocytes compared with the wild type, but it had no increased ability to cause infection. These findings indicate that increased resistance to antibody-dependent complement-mediated killing secondary to genetic deletion is not necessarily accompanied by increased virulence and suggest the presence of different mechanisms of antibody resistance.
鼠伤寒沙门氏菌ST313血清型导致非洲婴儿和感染HIV的成年人侵袭性疾病负担沉重。其特征是基因组降解(编码能力丧失),与引起肠炎的鼠伤寒沙门氏菌菌株相比,对抗体依赖性补体介导的杀伤的抗性增加。疫苗接种是一种有吸引力的疾病预防策略,主要候选疫苗侧重于诱导杀菌抗体。通过进一步基因缺失产生的抗抗体菌株可能会损害这种策略。将鼠伤寒沙门氏菌的饱和转座子插入突变体文库暴露于免疫血清中,鉴定出一组鼠伤寒沙门氏菌基因,当这些基因被中断时,会导致对血清杀伤的抗性增加。这些基因包括几个参与细菌包膜生物合成、蛋白质转运和代谢的基因。我们以鼠伤寒沙门氏菌SL1344为宿主生成了明确的突变衍生物。根据它们对杀伤增强抗性的初始水平,选择了 和 突变体进行进一步表征。鼠伤寒沙门氏菌 突变体失去了典型的杆状外观,对渗透压和去污剂应激表现出增加的敏感性,缺乏非常长的脂多糖,无法侵入肠上皮细胞,并表现出感染小鼠的能力下降。相比之下,鼠伤寒沙门氏菌 突变体与野生型相比,对渗透压和去污剂应激以及脂多糖谱具有相似的敏感性,并且感染肠上皮细胞的能力增加,但它引起 感染的能力没有增加。这些发现表明,继发于基因缺失的对抗体依赖性补体介导杀伤的抗性增加不一定伴随着毒力增加,并提示存在不同的抗体抗性机制。